Free tool
Cell therapy stocks
We cover 9 companies grouped under the Cell therapy theme. The median market value in the group is $300.07M. Across the group, the median move over the past trading day is +1.42%. Price change over the past year runs from −48.0% to +15.8% across the middle 80 percent of the group, with a median of −30.1%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
9 of 86 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| MSB.AX | Mesoblast Limited | 2.45 AUD | +19.85% | −11.73% | +1.03% |
| 4592.T | SanBio Company Limited | 997.00 JPY | +10.78% | −39.10% | −57.08% |
| 005690.KS | Pharmicell Co., Ltd. | 10,850.00 KRW | +20.82% | −24.76% | −0.03% |
| 219A.T | HEARTSEED INC | 2,435.00 JPY | +48.48% | +34.90% | −30.13% |
| 4894.T | Cuorips Inc. | 5,720.00 JPY | +35.06% | −8.04% | −15.38% |
| 4593.T | Healios K.K. | 286.00 JPY | +34.91% | +1.78% | −41.63% |
| 7774.T | Japan Tissue Engineering Co., Ltd. | 847.00 JPY | +40.00% | +44.79% | +75.00% |
| 504A.T | Innovacell Inc. | 570.00 JPY | +3.07% | −45.71% | −45.71% |
| OCC.AX | Orthocell Limited | 0.76 AUD | +6.29% | −32.14% | −36.67% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.